Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TRIL

Trillium Therapeutics (TRIL) Stock Price, News & Analysis

Trillium Therapeutics logo

About Trillium Therapeutics Stock (NASDAQ:TRIL)

Advanced Chart

Key Stats

Today's Range
$18.44
$18.44
50-Day Range
$17.50
$18.44
52-Week Range
$5.80
$20.96
Volume
8 shs
Average Volume
1.87 million shs
Market Capitalization
$1.94 billion
P/E Ratio
29.74
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TRIL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trillium Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRIL Stock News Headlines

Trillium Therapeutics Stock Price History
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
See More Headlines

TRIL Stock Analysis - Frequently Asked Questions

Trillium Therapeutics Inc. (NASDAQ:TRIL) issued its quarterly earnings data on Thursday, November, 18th. The biotechnology company reported ($0.18) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.19) by $0.01.

Based on aggregate information from My MarketBeat watchlists, some other companies that Trillium Therapeutics investors own include NVIDIA (NVDA), Golden Dragon (CPMD), FuelCell Energy (FCEL), Gilead Sciences (GILD), TG Therapeutics (TGTX), Inovio Pharmaceuticals (INO) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/18/2021
Today
8/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TRIL
CIK
1616212
Fax
N/A
Employees
33
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.62
Trailing P/E Ratio
29.74
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$59.35 million
Net Margins
N/A
Pretax Margin
-113,720.92%
Return on Equity
-23.31%
Return on Assets
-18.66%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
19.82
Quick Ratio
19.82

Sales & Book Value

Annual Sales
$150 thousand
Price / Sales
12,907.39
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.56 per share
Price / Book
7.20

Miscellaneous

Outstanding Shares
104,995,000
Free Float
95,440,000
Market Cap
$1.94 billion
Optionable
Optionable
Beta
2.08
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:TRIL) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners